PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.03%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
8.75%
Gross profit growth above 1.5x TSM's 4.47%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
73.22%
EBIT growth above 1.5x TSM's 4.22%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
73.22%
Operating income growth above 1.5x TSM's 4.22%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
102.27%
Net income growth above 1.5x TSM's 3.90%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
86.84%
EPS growth above 1.5x TSM's 4.27%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
86.84%
Diluted EPS growth above 1.5x TSM's 4.27%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.06%
Share count expansion well above TSM's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.25%
Diluted share count expanding well above TSM's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
104.86%
OCF growth above 1.5x TSM's 31.93%. David Dodd would confirm a clear edge in underlying cash generation.
117.14%
FCF growth 75-90% of TSM's 150.95%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
237.86%
10Y revenue/share CAGR 1.25-1.5x TSM's 162.64%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
33.74%
5Y revenue/share CAGR under 50% of TSM's 849.63%. Michael Burry would suspect a significant competitive gap or product weakness.
-29.90%
Negative 3Y CAGR while TSM stands at 57.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
2227.34%
OCF/share CAGR of 2227.34% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
84.38%
5Y OCF/share CAGR above 1.5x TSM's 26.98%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
63.76%
3Y OCF/share CAGR above 1.5x TSM's 13.12%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
359.68%
Net income/share CAGR at 50-75% of TSM's 675.38%. Martin Whitman might question if the firm’s product or cost base lags behind.
67.37%
5Y net income/share CAGR above 1.5x TSM's 15.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-36.47%
Negative 3Y CAGR while TSM is 143.41%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
552.25%
10Y equity/share CAGR above 1.5x TSM's 119.50%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
108.65%
5Y equity/share CAGR above 1.5x TSM's 27.13%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
15.59%
Below 50% of TSM's 31.54%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.70%
Firm’s AR is declining while TSM shows 1.20%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-8.55%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
14.80%
Asset growth above 1.5x TSM's 5.39%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.63%
BV/share growth above 1.5x TSM's 5.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.13%
We have some new debt while TSM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
5.40%
R&D growth drastically higher vs. TSM's 1.56%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
73.15%
SG&A growth well above TSM's 11.74%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.